407 related articles for article (PubMed ID: 26282005)
1. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of long non-coding RNA MALAT1 in cancer patients.
Wu Y; Lu W; Xu J; Shi Y; Zhang H; Xia D
Tumour Biol; 2016 Jan; 37(1):897-903. PubMed ID: 26254614
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis.
Song W; Zhang RJ; Zou SB
Minerva Med; 2016 Aug; 107(4):245-50. PubMed ID: 27348442
[TBL] [Abstract][Full Text] [Related]
4. [Long noncoding RNA MALAT1: a potential novel prognostic biomarkers in cancers based on Meta-analysis].
Song W; Wang K; Zhang R; Zou S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1163-1167. PubMed ID: 27932761
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract][Full Text] [Related]
6. Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis.
Wei Y; Niu B
Dis Markers; 2015; 2015():164635. PubMed ID: 26420912
[TBL] [Abstract][Full Text] [Related]
7. Clinical prognostic value of metastasis-associated lung adenocarcinoma transcript 1 in various human cancers: an updated meta-analysis.
Li Y; Yang Z; Wan X; Zhou J; Zhang Y; Ma H; Bai Y
Int J Biol Markers; 2016 May; 31(2):e173-82. PubMed ID: 26847605
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis.
Tian X; Xu G
BMJ Open; 2015 Sep; 5(9):e008653. PubMed ID: 26423854
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of long noncoding RNA MEG3 expression in the survival of patients with cancer: A meta-analysis.
Binabaj MM; Bahrami A; Bahreyni A; Shafiee M; Rahmani F; Khazaei M; Soleimanpour S; Ghorbani E; Fiuji H; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
J Cell Biochem; 2018 Nov; 119(11):9583-9590. PubMed ID: 30129051
[TBL] [Abstract][Full Text] [Related]
11. Correlation of increased MALAT1 expression with pathological features and prognosis in cancer patients: a meta-analysis.
Shi XS; Li J; Yang RH; Zhao GR; Zhou HP; Zeng WX; Zhou M
Genet Mol Res; 2015 Dec; 14(4):18808-19. PubMed ID: 26782531
[TBL] [Abstract][Full Text] [Related]
12. Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis.
Ghafouri-Fard S; Ashrafi Hafez A; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104330. PubMed ID: 31712117
[TBL] [Abstract][Full Text] [Related]
13. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
14. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
[TBL] [Abstract][Full Text] [Related]
15. Clinical Value of Long Noncoding RNA HOTAIR as a Novel Biomarker in Digestive Cancers: A Meta-Analysis.
Zhang Y; Zhou Y; Xu T; Tian W; Yang C; Wang X; Zhong S; Ran Q; Yang H; Zhu S
Technol Cancer Res Treat; 2018 Jan; 17():1533034618756783. PubMed ID: 29444619
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
Pang EJ; Yang R; Fu XB; Liu YF
Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis.
Shuai P; Zhou Y; Gong B; Jiang Z; Yang C; Yang H; Zhang D; Zhu S
Springerplus; 2016; 5(1):1721. PubMed ID: 27777857
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological role of long non-coding RNA UCA1 in various carcinomas.
Wang X; Peng F; Cheng L; Yang G; Zhang D; Liu J; Chen X; Zhao S
Oncotarget; 2017 Apr; 8(17):28373-28384. PubMed ID: 28423704
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA GAS5 can predict metastasis and poor prognosis: a meta-analysis.
Song W; Wang K; Zhang RJ; Dai QX; Zou SB
Minerva Med; 2016 Feb; 107(1):70-6. PubMed ID: 26763654
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis.
Song W; Zhang RJ; Zou SB
Minerva Med; 2016 May; ():. PubMed ID: 27186920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
